Previous studies have illustrated that lncRNA H19 activates the VEGF signaling pathway via sparing miR-138 to promote glioma angiogenesis [12], and that lncRNA BCYRN1 regulates the PTEN/AKT/p21 pathway to inhibit glioma tumorigenesis [13]. This evidence concerns the gene H19 and central nervous system cancer.